Loading...
Hesperidin ameliorates bleomycin-induced experimental pulmonary fibrosis via inhibition of TGF-beta1/Smad3/AMPK and IkappaBalpha/NF-kappaB pathways
Bleomycin (BLM) is a chemotherapeutic agent which is associated with Idiopathic pulmonary fibrosis (IPF) due to its chronic administration. Hesperidin, a bioflavonoid has been reported to possess antioxidant, anti-inflammatory, wound healing, and antiapoptotic potential. To evaluate the therapeutic...
Na minha lista:
| Udgivet i: | EXCLI J |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Leibniz Research Centre for Working Environment and Human Factors
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6785776/ https://ncbi.nlm.nih.gov/pubmed/31611754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17179/excli2019-1094 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|